150 related articles for article (PubMed ID: 6191672)
1. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
Umezawa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
[TBL] [Abstract][Full Text] [Related]
2. Antitumor antibiotics and low molecular weight immunomodifiers of microbial origin.
Umezawa H
Cancer Treat Rep; 1984 Jan; 68(1):137-44. PubMed ID: 6692425
[TBL] [Abstract][Full Text] [Related]
3. [Low molecular weight immunomodulators produced by microorganisms].
Ishizuka M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
[TBL] [Abstract][Full Text] [Related]
4. [Immunomodulation by antitumor antibiotics].
Ishizuka M
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
[TBL] [Abstract][Full Text] [Related]
5. Microbial secondary metabolites with potential use in cancer treatment. (Plasmid involvement in biosynthesis and compounds.
Umezawa H
Biomedicine; 1977 Jul; 26(4):236-49. PubMed ID: 72569
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight immunomodifiers produced by microorganisms.
Umezawa H; Ishizuka M
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S9-13. PubMed ID: 3842696
[TBL] [Abstract][Full Text] [Related]
7. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
[TBL] [Abstract][Full Text] [Related]
8. [New anthracycline antibiotics and derivatives].
Tatsuta K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
[TBL] [Abstract][Full Text] [Related]
9. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
10. [New direction in immunochemotherapy of cancer].
Nitta K
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1117-28. PubMed ID: 6191674
[TBL] [Abstract][Full Text] [Related]
11. [New trends in studies of the pharmacologic activity of microbial metabolites].
Chmiel A
Postepy Hig Med Dosw; 1989; 43(1):119-60. PubMed ID: 2697872
[TBL] [Abstract][Full Text] [Related]
12. [The structure and antitumor activity of antitumor antibiotics--recent progress].
Otake N
Gan To Kagaku Ryoho; 1988 Mar; 15(3):369-79. PubMed ID: 3279909
[TBL] [Abstract][Full Text] [Related]
13. [Japanese-French cooperation in tumor pharmacotherapy: 1970-1990].
Mathé G
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1050-70. PubMed ID: 6191671
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C.
Kelner MJ; McMorris TC; Rojas RJ; Trani NA; Estes L
Cancer Chemother Pharmacol; 2002 May; 49(5):412-8. PubMed ID: 11976836
[TBL] [Abstract][Full Text] [Related]
15. [Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines].
Ota K; Goto T; Fukushima M; Ariyoshi Y
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1352-61. PubMed ID: 6191712
[TBL] [Abstract][Full Text] [Related]
16. New microbial secondary metabolites under preclinical development for cancer treatment.
Umezawa H
Recent Results Cancer Res; 1978; 63():120-34. PubMed ID: 705007
[TBL] [Abstract][Full Text] [Related]
17. [The immunomodulating action of bestatin in the combined therapy of bladder cancer patients].
Neprina GS; Panteleeva ES; Vatin OE; Kariakin OB
Urol Nefrol (Mosk); 1994; (2):34-8. PubMed ID: 8017004
[TBL] [Abstract][Full Text] [Related]
18. [Experimental and clinical studies of bestatin as an immunomodulator].
Miwa H; Oka T; Tsurumi T; Sakae Y; Orita K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1019-24. PubMed ID: 7184437
[TBL] [Abstract][Full Text] [Related]
19. The antitumor effect of bleomycin combined with bestatin against Ehrlich ascites carcinoma in mice.
Kaya G; Akin C; Altuğ T; Devrim S
Proc Soc Exp Biol Med; 1988 Mar; 187(3):292-5. PubMed ID: 2450356
[TBL] [Abstract][Full Text] [Related]
20. Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin.
Berg K; Dietze A; Kaalhus O; Høgset A
Clin Cancer Res; 2005 Dec; 11(23):8476-85. PubMed ID: 16322311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
